Mometasone furoate and Small intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Small intestinal obstruction is found among people who take Mometasone furoate, especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Mometasone furoate and have Small intestinal obstruction. It is created by eHealthMe based on reports of 7,981 people who have side effects when taking Mometasone furoate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

7,981 people reported to have side effects when taking Mometasone furoate.
Among them, 12 people (0.15%) have Small intestinal obstruction.


What is Mometasone furoate?

Mometasone furoate has active ingredients of mometasone furoate. It is often used in asthma. eHealthMe is studying from 8,100 Mometasone furoate users for its effectiveness, alternative drugs and more.

What is Small intestinal obstruction?

Small intestinal obstruction (blockage in small intestine) is found to be associated with 1,490 drugs and 902 conditions by eHealthMe.

Number of Mometasone furoate and Small intestinal obstruction reports submitted per year:

Could Mometasone furoate cause Small intestinal obstruction?

Time on Mometasone furoate when people have Small intestinal obstruction *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Small intestinal obstruction when taking Mometasone furoate *:

  • female: 91.67 %
  • male: 8.33 %

Age of people who have Small intestinal obstruction when taking Mometasone furoate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 75 %
  • 50-59: 0.0 %
  • 60+: 25 %

Common drugs people take besides Mometasone furoate *:

  1. Ondansetron: 8 people, 66.67%
  2. Acetaminophen: 5 people, 41.67%
  3. Paclitaxel: 5 people, 41.67%
  4. Miralax: 5 people, 41.67%
  5. Magnesium Sulfate: 5 people, 41.67%
  6. Losartan Potassium: 5 people, 41.67%
  7. Prochlorperazine: 5 people, 41.67%
  8. Lorazepam: 5 people, 41.67%
  9. Lactulose: 5 people, 41.67%
  10. Ranitidine: 5 people, 41.67%

Common side effects people have besides Small intestinal obstruction *:

  1. Rhinorrhea (watery mucus discharge from the nose): 5 people, 41.67%
  2. Toothaches (tooth pain): 3 people, 25.00%
  3. Lower Respiratory Tract Infection: 3 people, 25.00%
  4. Abdominal Pain: 3 people, 25.00%
  5. Abdominal Pain Upper: 3 people, 25.00%
  6. Constipation: 3 people, 25.00%
  7. Diarrhea: 3 people, 25.00%
  8. Enthesopathy (disorder of entheses (bone attachments)): 3 people, 25.00%
  9. Fatigue (feeling of tiredness): 3 people, 25.00%
  10. Headache (pain in head): 3 people, 25.00%

Common conditions people have *:

  1. Fallopian Tube Cancer (cancer of fallopian tube): 5 people, 41.67%
  2. Stress And Anxiety: 3 people, 25.00%
  3. Ovarian Cancer (cancer of ovary): 3 people, 25.00%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 25.00%
  5. Irritable Bowel Syndrome: 3 people, 25.00%
  6. Inflammation: 3 people, 25.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
  8. Depression: 3 people, 25.00%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 25.00%
  10. Blood Magnesium Decreased: 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mometasone furoate and have Small intestinal obstruction?

Check whether Small intestinal obstruction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Small intestinal obstruction and when was it recovered:

Expand to all the drugs that have ingredients of mometasone furoate:

Alternative drugs to, pros and cons of Mometasone furoate:

Common Mometasone furoate side effects:

Browse all side effects of Mometasone furoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Small intestinal obstruction treatments and more:

COVID vaccines that are related to Small intestinal obstruction:

Common drugs associated with Small intestinal obstruction:

All the drugs that are associated with Small intestinal obstruction:

Common conditions associated with Small intestinal obstruction:

All the conditions that are associated with Small intestinal obstruction:

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate (the active ingredients of Mometasone furoate) and Mometasone furoate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: